Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Ensoma Announces $85 Million Financing and Agreement to Acquire Twelve Bio to Advance Portfolio of In Vivo Engineered Cellular Medicines
Nia JulianJanuary 5, 2023
Facebook0 Twitter Pinterest0 0 Likes
Previous

Carisma Therapeutics Closes Merger with Sesen Bio

Nia JulianMarch 8, 2023
Next

Kite and Arcellx Announce Strategic Collaboration to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma

Nia JulianDecember 12, 2022

© 2020 Solasta Ventures. All Rights Reserved.